C-MER Eye Care (03309.HK) Reports 183.2% YoY Revenue Surge from Aikangjian Dental in First Five Months of 2023

C-MER Medical (03309) announced that Shenzhen Aikangjianchi Group Co., Ltd. (formerly known as Shenzhen Aikangjian Dental Group Co., Ltd.) (a non-wholly owned subsidiary of the group) achieved significant growth in the first five months of 2023, benefiting from strong demand for high-quality dental services and the full reopening of borders between Hong Kong and Shenzhen.

According to the unaudited management accounts for the first five months of 2023, the unaudited consolidated revenue of Shenzhen Aikangjianchi Group Co., Ltd. surged from RMB 42.8 million in the same period in 2022 to RMB 121 million, representing a year-on-year increase of 183.2%. The revenue for the first five months of 2023 has already reached 99.0% of the company's audited revenue for the entire year of 2022, which was RMB 122 million. The company completed its investment in Shenzhen Aikangjianchi Group Co., Ltd. in February 2022.

Based on the financial and operational performance of Shenzhen Aikangjianchi Group Co., Ltd. in the first five months of 2023, the company expects its revenue for 2023 to be between RMB 280 million and RMB 300 million, becoming a major source of income for the group in addition to its core ophthalmology services.